前收市價 | 1.1000 |
開市 | 無 |
買盤 | 0.0000 |
賣出價 | 4.8000 |
拍板 | 350.00 |
到期日 | 2024-11-15 |
今日波幅 | 1.1000 - 1.1000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 2 |
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.